Intestinal CD11b+ B Cells Ameliorate Colitis by Secreting Immunoglobulin A

15Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The intestinal mucosal immune environment requires multiple immune cells to maintain homeostasis. Although intestinal B cells are among the most important immune cells, little is known about the mechanism that they employ to regulate immune homeostasis. In this study, we found that CD11b+ B cells significantly accumulated in the gut lamina propria and Peyer’s patches in dextran sulfate sodium-induced colitis mouse models and patients with ulcerative colitis. Adoptive transfer of CD11b+ B cells, but not CD11b−/− B cells, effectively ameliorated colitis and exhibited therapeutic effects. Furthermore, CD11b+ B cells were found to produce higher levels of IgA than CD11b− B cells. CD11b deficiency in B cells dampened IgA production, resulting in the loss of their ability to ameliorate colitis. Mechanistically, CD11b+ B cells expressed abundant TGF-β and TGF-β receptor II, as well as highly activate phosphorylated Smad2/3 signaling pathway, consequently promoting the class switch to IgA. Collectively, our findings demonstrate that CD11b+ B cells are essential intestinal suppressive immune cells and the primary source of intestinal IgA, which plays an indispensable role in maintaining intestinal homeostasis.

Cite

CITATION STYLE

APA

Fu, Y., Wang, Z., Yu, B., Lin, Y., Huang, E., Liu, R., … Chu, Y. (2021). Intestinal CD11b+ B Cells Ameliorate Colitis by Secreting Immunoglobulin A. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.697725

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free